FDA grants Orphan Drug Designation for Inflazome’s Inzomelid for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) by Seini Moimoi | Jul 14, 2020 | Portfolio News
89bio Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares by Seini Moimoi | Jul 13, 2020 | Portfolio News
Poseida Therapeutics Announces Pricing of Initial Public Offering by Seini Moimoi | Jul 9, 2020 | Portfolio News
FDA Approves Talaris Therapeutics’ IND for its Allogeneic Cell Therapy FCR001 to be Evaluated in Patients with a Severe Form of Scleroderma by Seini Moimoi | Jul 8, 2020 | Portfolio News
